Defining species-specific and conserved interactions of apical membrane protein 1 during erythrocyte invasion in malaria to inform multi-species vaccines

• Published in: Cellular and molecular life sciences : CMLS Vol. 80; no. 3; p. 74
• Main Authors: Drew, Damien R., Wilson, Danny W., Weiss, Gretchen E., Yeoh, Lee M., G. Henshall, Isabelle, Crabb, Brendan S., Dutta, Sheetij, Gilson, Paul R., Beeson, James G.
• Format: Journal Article
• Language: English
• Published: Cham Springer International Publishing 01.03.2023; Springer Nature B.V
• Subjects: Ablation; Amino acids; Antibodies; Antigens; Apical membrane antigen 1; Binding; Biochemistry; Biomedical and Life Sciences; Biomedicine; Cell Biology; Cell Membrane - metabolism; Divergence; Domains; Erythrocytes; Erythrocytes - metabolism; Erythrocytes - parasitology; Humans; Invasive species; Life Sciences; Malaria; Malaria - genetics; Malaria - metabolism; Malaria - parasitology; Malaria - prevention & control; Membrane proteins; Membrane Proteins - genetics; Membrane Proteins - metabolism; Membranes; Mutation; Original; Original Article; Plasmodium falciparum; Proteins; Protozoan Proteins - genetics; Protozoan Proteins - metabolism; Residues; Vaccine development; Vaccines; Vector-borne diseases; Antibodies; Inhibition; Peptides; RON2; Therapeutics; Plasmodium falciparum; Plasmodium vivax
• ISSN: 1420-682X; 1420-9071
• DOI: 10.1007/s00018-023-04712-z

Plasmodium falciparum and P. vivax are the major causes of human malaria, and P. knowlesi is an important additional cause in SE Asia. Binding of apical membrane antigen 1 (AMA1) to rhoptry neck protein 2 (RON2) was thought to be essential for merozoite invasion of erythrocytes by Plasmodium spp. Our findings reveal that P. falciparum and P. vivax have diverged and show species-specific binding of AMA1 to RON2, determined by a β-hairpin loop in RON2 and specific residues in AMA1 Loop1E. In contrast, cross-species binding of AMA1 to RON2 is retained between P. vivax and P. knowlesi . Mutation of specific amino acids in AMA1 Loop1E in P. falciparum or P. vivax ablated RON2 binding without impacting erythrocyte invasion. This indicates that the AMA1–RON2-loop interaction is not essential for invasion and additional AMA1 interactions are involved. Mutations in AMA1 that disrupt RON2 binding also enable escape of invasion inhibitory antibodies. Therefore, vaccines and therapeutics will need to be broader than targeting only the AMA1–RON2 interaction. Antibodies targeting AMA1 domain 3 had greater invasion-inhibitory activity when RON2-loop binding was ablated, suggesting this domain is a promising additional target for vaccine development. Targeting multiple AMA1 interactions involved in invasion may enable vaccines that generate more potent inhibitory antibodies and address the capacity for immune evasion. Findings on specific residues for invasion function and species divergence and conservation can inform novel vaccines and therapeutics against malaria caused by three species, including the potential for cross-species vaccines.